Trial Results Support Transition into Late-Stage Development with Program Expected to be Phase 2b/3-ready in H2 2026 BERLIN, GERMANY, January 29, 2026 – OMEICOS, a clinical-stage biopharmaceutical ...
On the heels of positive year-end results, Sephora's executive leadership team has come to New York to hold the retailer's first global summit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results